Board of Directors

Our Board of Directors is a group of volunteers committed to FBC’s mission to find treatments and cures for blinding eye diseases. The Board includes representatives from the corporate and medical worlds, as well as individuals affected by vision loss.

Executive Committee & Officers

Tara James, Chair, Lawyer, RBC, Toronto, Ontario

Andrew Burke, Past Chair, Partner, Stewart McKelvey, Halifax, Nova Scotia

George Sheen, Vice Chair & Treasurer, Partner, PwC (retired), Toronto, Ontario

Stephen Aylward, Corporate Secretary, Lawyer, Stockwoods LLP, Toronto, Ontario

Laurie Young, Executive Member, CEO (retired), Ogilvy Canada, Toronto, Ontario

Mary Ashbourne Smith, Executive Member, Vice President (retired), TD Finance Shared Services, Toronto, Ontario

Directors

Michel Cayouette, PhD, Research Unit Director, Institut de recherche cliniques de Montreal (IRCM), Research Associate Professor, University of Montreal, Montreal, Quebec

Netan Choudhry, MD, FRCS(C), DABO, Co-founder and Medical Director at Vitreous Retina Macular Specialists of Toronto, Toronto, Ontario

David Drury, Managing Director, IBM Canada Ltd., Toronto, Ontario

Selena Friesen, OD, Optometrist, Waverley Eye Care, Winnipeg, Manitoba

Anne Loiselle, Executive Director, EQ Healthcare Ltd., Montreal, Quebec

Donald F. Reed, President and CEO, Franklin Templeton Investments Corp. (retired), Toronto, Ontario

Robert F. Richards, Chairman, Heathbridge Capital Management Ltd., Toronto, Ontario

Jim Riley, Managing Director & COO, The Catalyst Capital Group Inc., Toronto, Ontario

Mike Seed, CIM, First Vice President & Portfolio Manager, Seed Financial Group, CIBC Wood Gundy, Edmonton, Alberta

Tahir Shafiq, Independent Management Consultant, Markham, Ontario

Rob Simmons,  Partner, Doberman Pictures, Vancouver BC

Deepa Yoganathan, MD, FRCSC, DABO, Ophthalmologist, Windsor Eye Associates, Windsor, Ontario, and Assistant Professor in the Department of Ophthalmology and Vision Sciences, University of Toronto